OncoCyte Corp Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoCyte Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OncoCyte Corp for December 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 28 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Option Exercise | M | 1.34 | 65,271 | 87,463 | 0 | |
Dec 28 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Option Exercise | M | 1.34 | 1,237 | 1,658 | 65,271 | |
Dec 28 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Buy | M | 1.34 | 65,271 | 87,463 | 384,111 | 318.8 K to 384.1 K (+20.47 %) |
Dec 28 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Sell | S | 2.55 | 900 | 2,295 | 318,840 | 319.7 K to 318.8 K (-0.28 %) |
Dec 28 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Buy | M | 1.34 | 1,237 | 1,658 | 319,740 | 318.5 K to 319.7 K (+0.39 %) |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Option Exercise | M | 1.34 | 10,516 | 14,091 | 66,508 | |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Option Exercise | M | 1.34 | 47,976 | 64,288 | 77,024 | |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Sell | S | 0.00 | 7,652 | 0 | 318,503 | 326.2 K to 318.5 K (-2.35 %) |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Buy | M | 1.34 | 10,516 | 14,091 | 326,155 | 315.6 K to 326.2 K (+3.33 %) |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Sell | S | 2.54 | 5,148 | 13,076 | 315,639 | 320.8 K to 315.6 K (-1.60 %) |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Sell | S | 0.00 | 30,000 | 0 | 320,787 | 350.8 K to 320.8 K (-8.55 %) |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Buy | M | 1.34 | 47,976 | 64,288 | 350,787 | 302.8 K to 350.8 K (+15.84 %) |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Option Exercise | M | 1.34 | 10,516 | 14,091 | 66,508 | |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Option Exercise | M | 1.34 | 47,976 | 64,288 | 77,024 | |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Sell | S | 0.00 | 7,652 | 0 | 318,503 | 326.2 K to 318.5 K (-2.35 %) |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Buy | M | 1.34 | 10,516 | 14,091 | 326,155 | 315.6 K to 326.2 K (+3.33 %) |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Sell | S | 2.54 | 5,148 | 13,076 | 315,639 | 320.8 K to 315.6 K (-1.60 %) |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Sell | S | 0.00 | 30,000 | 0 | 320,787 | 350.8 K to 320.8 K (-8.55 %) |
Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Buy | M | 1.34 | 47,976 | 64,288 | 350,787 | 302.8 K to 350.8 K (+15.84 %) |
Dec 15 2020 | OCX | OncoCyte Corp | Sundar Padmavathi | SVP, Marketing & Ma ... | Grant | A | 0.00 | 4,177 | 0 | 4,177 | 0 to 4.2 K |
Dec 15 2020 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | CSO | Grant | A | 0.00 | 6,603 | 0 | 7,477 | 874 to 7.5 K (+755.49 %) |
Dec 15 2020 | OCX | OncoCyte Corp | Arno Andrew | Director | Grant | A | 0.00 | 9,602 | 0 | 112,049 | 102.4 K to 112 K (+9.37 %) |
Dec 15 2020 | OCX | OncoCyte Corp | Last Andrew J. | Director | Grant | A | 0.00 | 16,184 | 0 | 23,177 | 7 K to 23.2 K (+231.43 %) |
Dec 15 2020 | OCX | OncoCyte Corp | Parker Albert P | COO | Grant | A | 0.00 | 5,586 | 0 | 10,586 | 5 K to 10.6 K (+111.72 %) |
Dec 15 2020 | OCX | OncoCyte Corp | Ross Douglas T. | CMO | Grant | A | 0.00 | 5,317 | 0 | 5,317 | 0 to 5.3 K |
Dec 15 2020 | OCX | OncoCyte Corp | Redmond Cavan M. | Director | Grant | A | 0.00 | 18,416 | 0 | 70,863 | 52.4 K to 70.9 K (+35.11 %) |
Dec 15 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Grant | A | 0.00 | 5,909 | 0 | 302,811 | 296.9 K to 302.8 K (+1.99 %) |
Dec 15 2020 | OCX | OncoCyte Corp | Levine Mitchell S | CFO | Grant | A | 0.00 | 10,121 | 0 | 46,700 | 36.6 K to 46.7 K (+27.67 %) |